News

June 19, 2018June 19, 2018

Atara Biotherapeutics Study Links Epstein-Barr Virus Infection with MS

News

Analysis of post-mortem brain samples from multiple sclerosis (MS) patients and healthy individuals (without neurologic disease) showed that while signs of Epstein-Barr virus (EBV) infection are ... Read more

June 19, 2018June 19, 2018

#EAN2018 – Ocrevus Lowers Relapse Rates Over Long Term and Better Than Rebif Does, Data Show

News

Long-term treatment with Ocrevus (ocrelizumab)  — as well as switching from Rebif (interferon beta-1a) to Ocrevus — leads to a significant and sustained reduction in disease ... Read more

June 18, 2018June 18, 2018

First Clinical Trial to Focus on Improving Hand Function in PPMS Patients Announced

News

A new clinical trial will be the first in the world to recognize the importance of retaining hand function for wheelchair-bound patients with primary progressive MS ... Read more

June 18, 2018June 18, 2018

MSAA Expands Financial Aid Fund for MRI Scans to Meet Growing Demand

News

The Multiple Sclerosis Association of America (MSAA) announced that it will expand its MRI Access Fund to help meet the growing demand for magnetic resonance imaging (MRI) tests ... Read more

June 15, 2018June 15, 2018

#EAN2018 – Ocrevus May Delay Progression to Wheelchair by Up to 7 Years, New Analysis of PPMS Patient Data Shows

News

Treatment with Ocrevus (ocrelizumab) slows disability progression in primary progressive multiple sclerosis (PPMS) in ways that may be of considerable importance to patients — including the ... Read more

June 15, 2018June 15, 2018

Discovery of ‘Fiery’ Cell Death Mechanism May Be MS ‘Game-Changer’

News

Researchers have unveiled a new cell death mechanism called pyroptosis — also known as “fiery death” — as a main factor driving neurodegeneration and loss of myelin ... Read more

June 14, 2018June 14, 2018

Obesity and Smoking in Teen Years Could Speed Adult’s Progression to SPMS, Study Reports

News

Young adults at age 20 who are obese and smoke are not only at a higher risk of developing relapsing multiple sclerosis — those who become ... Read more

June 14, 2018June 14, 2018

MyoPro Powered Arm Brace Now Available for Teens with MS or Injuries, Myomo Announces

News

Myomo, a wearable medical robotics company, announced that MyoPro — its myoelectric orthosis or powered brace — is now available for use by teenagers with paralyzed or weakened ... Read more

June 13, 2018June 13, 2018

Effectiveness of Gilenya and Tecfidera Compared in Real-World Study in Italy

News

Gilenya (fingolimod) and Tecfidera (dimethyl fumarate) are equally effective as first-line treatments in people with relapsing-remitting multiple sclerosis (RRMS), but Gilenya may be of slightly more benefit ... Read more

June 13, 2018June 13, 2018

MMJ Bioscience Files Request with FDA to Open Phase 2 Study of Medical Cannabis in Progressive MS

News

MMJ Bioscience, which specializes in medical cannabis products, has filed a request with the U.S. Food and Drug Administration (FDA) to open Phase 2 clinical trials ... Read more

June 12, 2018June 12, 2018

Gilenya Seen to Particularly Benefit Young Adults with Higher Relapse Rates, Trial Data Show

News

Young adults with multiple sclerosis (MS) have higher relapse rates and respond better to Gilenya treatment compared to the overall MS population, data from a post hoc ... Read more

June 12, 2018June 12, 2018

Perceptions of Fall Risk as Important as Physical Limitations and Need Be Part of Risk Assessment, Study Says

News

For ambulatory multiple sclerosis patients with mobility problems, perceptions of being at risk of falling are as important as the risk due to their physical condition ... Read more

June 11, 2018June 11, 2018

Vagus Nerve Signals Could Work as ‘Early Warning System’ for Inflammation in MS and Other Disease, Study Says

News

A new way of interpreting inflammatory signals using the vagus nerve — which carries such signals from throughout the body to the brain — has been ... Read more

June 11, 2018June 11, 2018

BIIB098 Showing Ability in Studies To Be Easier on GI Tract Than Tecfidera, Earning Alkermes $50M from Biogen

News

Alkermes announced that it has received a $50 million payment from Biogen after a review of preliminary data related to the gastrointestinal tolerability of BIIB098 (diroximel fumarate), now ... Read more

June 8, 2018June 8, 2018

Workplace Dress Codes Can Limit Opportunities for People with Disabilities, Researchers Say

News

Researchers at the University of Missouri found that a lack of appropriate clothing designed for people with disabilities, caused by accidents or chronic diseases like multiple sclerosis ... Read more

June 8, 2018June 8, 2018

Mobility Devices for People Who Have Lower-Limb Paralysis are Flawed, Online Survey Reveals

News

More investment and new technological developments are needed to assist people who have limited mobility because of lower-limb paralysis. That was the major conclusion of an ... Read more

June 7, 2018June 8, 2018

Atrophy of Brain Lesions Predicts Disability in MS, 10-year Study Finds

News

Atrophy (shrinkage) of brain lesions correlates with physical disability in patients with multiple sclerosis (MS), new research reports. The study, “Atrophied Brain Lesion Volume: A New ... Read more

June 7, 2018June 8, 2018

#CMSC2018 – Pharmacist Discusses Advances, Challenges in Cannabinoids Research to Treat MS

News

Several studies have demonstrated the therapeutic potential of cannabis and its derivate products to manage the symptoms of multiple sclerosis (MS) and other neurodegenerative diseases. But ... Read more

June 6, 2018June 6, 2018

#CMSC2018 — Inhibiting Oxidative Stress Enzyme Promotes Resealing of Blood-Brain Barrier in MS Mouse Model

News

Inhibiting an oxidative stress enzyme called myeloperoxidase protects the blood-brain barrier in a mouse model of multiple sclerosis (MS), limiting the migration of immune cells and ... Read more

June 6, 2018June 6, 2018

Canada Trails US in Patient Access to Rare Disease Therapies, CORD President Says

News

Canada’s healthcare system is excellent for people with common ailments like diabetes or high blood pressure, but it’s “basically failing the nearly three million Canadians with ... Read more

June 6, 2018June 6, 2018

#CMSC2018 – Gains in Functional Abilities Seen in Lemtrada-treated MS Patients Over Six Years, CARE-MS II Extension Study Shows

News

Patients with active relapsing-remitting multiple sclerosis (MS) continue to show improvement — lesser functional disability across a variety of measures — and often without the need ... Read more

June 5, 2018June 5, 2018

#CMSC2018 — Advances Made in Care of Children with MS, but Challenges Remain, Expert Says

News

While the treatment and care of children and teenagers with multiple sclerosis (MS) has seen many developments in recent years, there are still many challenges to ... Read more

June 5, 2018June 7, 2018

#CMSC2018 – New Phase 2 Data Supports Ublituximab in Effectively Lowering Relapses, Depleting B-cells in MS Patients

News

New results from a Phase 2 trial evaluating TG Therapeutics’ ublituximab continue to support the therapy’s efficacy in treating relapsing forms of multiple sclerosis (MS). This ... Read more

June 5, 2018June 5, 2018

Oryzon Genomics Readies Updates on ORY-2001, Being Tested in MS Patients in Phase 2 Trial

News

Oryzon Genomics will give updates on its leading investigational product ORY-2001, a brain-targeting epigenetic therapy now in a Phase 2 clinical trial recruiting multiple sclerosis patients, ... Read more

June 4, 2018June 4, 2018

Family Support and Identity Seen to Affect Depression, Mood Swings in MS Patients in UK Study

Alexa, News

A survey of multiple sclerosis (MS) patients that looked at their sense of social identity based on their family relations — meant to help explain mood disorders ... Read more

June 4, 2018June 4, 2018

PathMaker Neurosystems, Developing MyoRegulator for Spasticity, Named Startup of Year at French-American Business Gala

News

PathMaker Neurosystems, which specializes in non-invasive devices to treat chronic neuromotor disorders, won the 2018 French-American Business (FAB) Award in the startup/small company category. PathMaker, based in Boston, ... Read more

June 1, 2018June 1, 2018

MS Groups Working to Advance Patient-Reported Outcomes in Research, Patient Care and Treatment Development

News

Two groups working to collect and promote patient-reported outcomes (PROs) in research and treatment for multiple sclerosis (MS) announced they will jointly explore ways to “standardize and harmonize” these ... Read more

June 1, 2018June 7, 2018

Chemical that Stimulates Estrogen Receptors Seen to Promote Myelin Repair Through ‘Good’ Inflammation in Mouse MS Model

News

A chemical compound called indazole chloride promotes repair of myelin, the protective layer of nerve fibers, through “beneficial” inflammation in a mouse model of multiple sclerosis ... Read more

May 31, 2018June 7, 2018

Individual Temperament Can Affect Health-Related Quality of Life of MS Patients, Study Shows

News

The temperament of patients with multiple sclerosis (MS) can have a significant impact on their health-related quality of life, a study suggests. The study, “Health-related quality of ... Read more

May 31, 2018May 31, 2018

HPV Vaccine Not Seen to Raise Risk of Autoimmune Disease in Canadian Study

News

Girls given the quadrivalent human papillomavirus (HPV4) vaccination, commercialized as Gardasil, showed no increased risk of developing autoimmune diseases like multiple sclerosis (MS), according to a new ... Read more

May 30, 2018May 30, 2018

With Support of AARDA, Autoimmunity Institute Aims to Better Understand and Treat Diseases Like MS

News

The American Autoimmune Related Diseases Association (AARDA) is partnering with Allegheny Health Network (AHN) and its newly opened Autoimmunity Institute — based in Pittsburgh, Pennsylvania — to study ... Read more

May 30, 2018June 4, 2018

Study Examines Factors That Increase Risk of Progressing from RRMS to SPMS

News

Age at disease onset, number of early relapses, and the extent of brain damage at baseline can help identify those who are at high risk of ... Read more

May 29, 2018May 29, 2018

MS Patients Generally Able to Maintain Healthy Lifestyle Changes, Study Shows

News

In general, multiple sclerosis (MS) patients are able to make and sustain healthy lifestyle changes associated with a better quality of life, a study shows. The study, ... Read more

May 29, 2018May 29, 2018

North Carolina Couple Donate $20,000 to Discovery MS Initiative at Murdock Research Institute

News

A North Carolina couple living with multiple sclerosis have raised more than $20,000 so far this year to support Discovery MS, a nonprofit research initiative that is part of ... Read more

May 25, 2018May 25, 2018

2 Common Tests Used to Assess Deficits in MS Produce Different Results, Study Finds

News

Learning impairments in multiple sclerosis (MS) are detected differently by the two most commonly used neuropsychological tests, a new study by the Kessler Foundation shows. The ... Read more

May 25, 2018May 30, 2018

Limited Use of Large Muscles Affects Health of Nerve Cell-producing Stem Cells in Brain, Mouse Study Finds

News

Lesser time spent exercising and using large muscles can result in serious alterations in the metabolism of brain stem cells and their ability to generate new nerve ... Read more

May 24, 2018May 24, 2018

Brain Stimulation Done at Slower Rates May Be Best for MS and Other Patients as Neurons ‘Tire,’ Study Says

News

A non-invasive procedure using magnetic pulses to stimulate the brain may be more effective in treating multiple sclerosis (MS) and other patients if the rate of stimulation is ... Read more

May 24, 2018May 24, 2018

Gilenya Tied to Treatment Satisfaction, Quality of Life in MS Patients

News

Treatment with Gilenya (fingolimod) is associated with treatment satisfaction, which, in turn, is linked to a better quality-of-life in patients with relapsing-remitting multiple sclerosis (RRMS), a study ... Read more

May 23, 2018May 23, 2018

Subcutaneous Ofatumumab a Safe, Effective RRMS Therapy at Low Doses, Trial Results Show

News

A formulation of ofatumumab (brand name Arzerra) to be injected under the skin (subcutaneous) was found to be safe and effective in the treatment of relapsing-remitting ... Read more

May 23, 2018May 23, 2018

European EMA Confirms Severe Risks Associated with MS Medicine Zinbryta

News

A review of data concerning the multiple sclerosis (MS) medicine Zinbryta (daclizumab) confirmed its association with the risk of developing severe and potentially fatal immune reactions ... Read more